Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

15:21 EST 12 Dec 2018 | NEJM

More From BioPortfolio on "Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance"